menu
    • menu

    Company profile for Mannkind

    NEW Drugs in Dev: 16
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MannKind Corporation (NASDAQ:MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company's first FDA-approved product and the only orally inhaled ultra rapid-acting mealtime insulin in the United States, where it is available b...
    MannKind Corporation (NASDAQ:MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company's first FDA-approved product and the only orally inhaled ultra rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MannkindUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    30930 Russell Ranch Road, Suite 300 Westlake Village, CA 91362
    Telephone
    Telephone
    818.661.5000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://mannkindcorp.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mannkind-corporation
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/MannKindCorp

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MannKind's Afrezza Highlight Pediatric & Pregnancy Use at ADA
    MannKind's Afrezza Highlight Pediatric & Pregnancy Use at ADA

    05 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/05/3307663/29517/en/data-at-ada-2026-highlights-key-findings-from-clinical-and-real-world-studies-of-mannkind-s-afrezza-inhaled-insulin-across-pediatric-care-pregnancy-and-use-with-automated-insulin-d.html

    GLOBENEWSWIRE
    05 Jun 2026
    Share Share
    MannKind Completes INFLO-1 Randomization, Doses First in INFLO-2
    MannKind Completes INFLO-1 Randomization, Doses First in INFLO-2

    03 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/03/3305858/29517/en/mannkind-enters-data-rich-development-period-with-completion-of-randomization-in-phase-1b-inflo-1-study-and-enrollment-of-first-patient-in-phase-2-inflo-2-trial-for-nintedanib-dpi-.html

    GLOBENEWSWIRE
    03 Jun 2026
    Share Share
    MannKind Announces FDA Approval of Afrezza, for Use in Children
    MannKind Announces FDA Approval of Afrezza, for Use in Children

    29 May 2026

    // PRESS RELEASE

    https://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-announces-fda-approval-afrezzar-first-and-only-inhaled

    PRESS RELEASE
    29 May 2026
    Share Share
    MannKind to Present Afrezza Data in Pediatrics at ADA 2026
    MannKind to Present Afrezza Data in Pediatrics at ADA 2026

    27 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/27/3302065/29517/en/mannkind-to-showcase-new-data-at-ada-2026-advancing-understanding-of-inhaled-insulin-afrezza-in-pediatric-care-pregnancy-and-use-with-automated-insulin-delivery-aid-systems.html

    GLOBENEWSWIRE
    27 May 2026
    Share Share
    Mannkind To Present At Jefferies Global Healthcare Conference
    Mannkind To Present At Jefferies Global Healthcare Conference

    27 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/27/3302352/29517/en/mannkind-to-present-at-jefferies-global-healthcare-conference.html

    GLOBENEWSWIRE
    27 May 2026
    Share Share
    MannKind Pursues Ralinepag DPI for Pulmonary Hypertension
    MannKind Pursues Ralinepag DPI for Pulmonary Hypertension

    06 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/06/3288615/29517/en/mannkind-announces-ralinepag-dry-powder-inhalation-dpi-program-to-be-pursued-for-pulmonary-hypertension-and-fibrotic-lung-diseases.html

    GLOBENEWSWIRE
    06 May 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Mannkind and get a quotation

    Mannkind is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find Insulin bulk with DMF offered by Mannkind

    Find Treprostinil Sodium bulk with DMF offered by Mannkind

    Find Insulin bulk offered by Mannkind

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search